NEW YORK (GenomeWeb) – MDxHealth today announced a partnership with SouthGenetics to market its ConfirmMDx test for prostate cancer in Latin America.

Under the terms of the agreement, Montevideo, Uruguay-based SouthGenetics secures rights to commercialize ConfirmMDx for Prostate Cancer in Argentina, Bolivia, Chile, Colombia, the Dominican Republic, Ecuador, Mexico, Peru, Panama, Paraguay, Uruguay, and Venezuela. Financial and other details of the agreement were not disclosed.

All tests will be processed at MDxHealth's CLIA-certified laboratory in Irvine, California.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.